Supernus Pharmaceuticals | Salg Og Administrasjonskostnader

Selling And Administration Expenses Endring Dato
Abbott USD 2.96B 269M 2024-03
ANI Pharmaceuticals USD 48.02M 3.56M 2024-03
Aurora Cannabis CAD 37.2M 2.72M 2023-12
Bristol-Myers Squibb USD 2.37B 303M 2024-03
Canopy Growth CAD 41.28M 9.72M 2024-03
Corcept Therapeutics USD 56.27M 9.12M 2024-03
Eisai JPY 92.17B 616M 2023-12
Eli Lilly USD 1.84B 88.5M 2024-03
Pacira USD 72.03M 6.22M 2024-03
Perrigo USD 305.6M 1.2M 2024-03
Pfizer USD 3.5B 976M 2024-03
Supernus Pharmaceuticals USD 86.52M 5.23M 2024-03
United Therapeutics USD 144.4M 15.8M 2024-03
Xeris Pharmaceuticals USD 38.38M 812K 2024-03



Supernus Pharmaceuticals Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.